FDA Approves Genzyme's AUBAGIO (Teriflunomide), A Once-Daily, Oral...

Full story: BioResearch Online
Genzyme, aSanofi company , announced today that the U.S. Food and Drug Administration has approved AUBAGIO as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis . Full Story

Austin, TX

#1 Jan 15, 2013
Want to learn more about Aubagio? Check out http://www.rxwiki.com/aubagio

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Health Discussions

Title Updated Last By Comments
Algoma Public Health prepares to buttsmack outd... 45 min Mother 1
Nurse anesthetists aren't the same as anesthesi... (Sep '10) 4 hr Razorback 118
Floridian and son navigate autism 4 hr sam 1
Autism and stress at holiday time 7 hr Vaccine Damage 1
Vaccines and Autism 7 hr friend DUHZ it again 8
My Champix Nightmare (May '08) 8 hr parboy 72
Childhood exposure to Libby amphibole during ou... 9 hr The Hat 2
Pregnancy Symptoms - 12 Very Early Symptoms of ... (Jun '07) Dec 18 Cece 6,016
More from around the web